Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vermylen

Showing results (11-20 of 373) with videos related to

Pageof 38
Sort By:
Journal Des Maladies Vasculaires|January 1, 1987
[Molecular defects of coagulation factors and of the fibrinolytic system associated with thromboembolism]M Verstraete, J Vermylen
British Journal of Haematology|October 1, 1976
Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIIIJ Vermylen, D Bottecchia
European Journal of Haematology. Supplementum|January 12, 1999
Optimal care of inhibitor patients during surgeryJ Vermylen, K Peerlinck
Journal of Dental Research|May 1, 1984
Wound healing following dental extractions in rabbits: effects of tranexamic acid, warfarin anti-coagulation, and socket packingF Vinckier, J Vermylen
The New England Journal of Medicine|November 29, 1984
Antithrombotic potential of low-dose aspirinM Verstraete, J Vermylen
British Journal of Haematology|May 1, 1977
Evidence that washed human platelets possess factor-X activator activityN Semeraro, J Vermylen
Acta Clinica Belgica|January 1, 1986
The labyrinth of bleeding disorders. An algorithm based on five testsM Verstraete, J Vermylen
Acta Clinica Belgica|January 1, 1991
Epidemic of factor VIII inhibitors linked to factor VIII-PJ Vermylen, K Peerlinck
Vox Sanguinis|January 1, 1994
Review of the hepatitis A epidemics in hemophiliacs in EuropeJ Vermylen, K Peerlinck
British Journal of Clinical Pharmacology|January 1, 1983
Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observationsJ Vermylen, H Deckmyn
Pageof 38

Showing results (11-20 of 373) with videos related to

Sort By:
Pageof 38
Journal Des Maladies Vasculaires|January 1, 1987
[Molecular defects of coagulation factors and of the fibrinolytic system associated with thromboembolism]M Verstraete, J Vermylen
British Journal of Haematology|October 1, 1976
Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIIIJ Vermylen, D Bottecchia
European Journal of Haematology. Supplementum|January 12, 1999
Optimal care of inhibitor patients during surgeryJ Vermylen, K Peerlinck
Journal of Dental Research|May 1, 1984
Wound healing following dental extractions in rabbits: effects of tranexamic acid, warfarin anti-coagulation, and socket packingF Vinckier, J Vermylen
The New England Journal of Medicine|November 29, 1984
Antithrombotic potential of low-dose aspirinM Verstraete, J Vermylen
British Journal of Haematology|May 1, 1977
Evidence that washed human platelets possess factor-X activator activityN Semeraro, J Vermylen
Acta Clinica Belgica|January 1, 1986
The labyrinth of bleeding disorders. An algorithm based on five testsM Verstraete, J Vermylen
Acta Clinica Belgica|January 1, 1991
Epidemic of factor VIII inhibitors linked to factor VIII-PJ Vermylen, K Peerlinck
Vox Sanguinis|January 1, 1994
Review of the hepatitis A epidemics in hemophiliacs in EuropeJ Vermylen, K Peerlinck
British Journal of Clinical Pharmacology|January 1, 1983
Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observationsJ Vermylen, H Deckmyn
Pageof 38